Zurit Levine

Direttore Tecnico/Scientifico/R&S presso COMPUGEN LTD.

56 anni

Health Technology

Consumer Services

Posizioni attive di Zurit Levine

Società	Posizione	Inizio	Fine
COMPUGEN LTD.	Direttore Tecnico/Scientifico/R&S	01/01/2018	-
COMPUGEN LTD.	Corporate Officer/Principal	01/01/1999	01/01/2018

Società	Posizione	Inizio	Fine
Therapeutic Discovery Corp. Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA.	Direttore/Membro del Consiglio	-	01/01/2007
Neviah Genomics Ltd. Neviah Genomics Ltd. Pharmaceuticals: MajorHealth Technology Neviah Genomics Ltd. develops novel biomarkers for the prediction of drug-induced toxicity. It identifies biomarkers for the prediction of drug-induced toxicity. The firm offers involving cell harvest and culture, compound exposure, mRNA expression analysis and multi-parameter mathematical computation. The company was founded in 2012 and is headquartered in Yavne, Israel.	Direttore/Membro del Consiglio	-	-

Tel-Aviv University

Doctorate Degree

Distribuzione geografica

Israele	4
Stati Uniti	2

Posizioni

Director/Board Member	2
Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1

Settori

Health Technology	4
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
COMPUGEN LTD.	Health Technology

Aziende private	2
Therapeutic Discovery Corp. Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA.	Health Technology
Neviah Genomics Ltd. Neviah Genomics Ltd. Pharmaceuticals: MajorHealth Technology Neviah Genomics Ltd. develops novel biomarkers for the prediction of drug-induced toxicity. It identifies biomarkers for the prediction of drug-induced toxicity. The firm offers involving cell harvest and culture, compound exposure, mRNA expression analysis and multi-parameter mathematical computation. The company was founded in 2012 and is headquartered in Yavne, Israel.	Health Technology

Aziende private

Health Technology